NCT04855019

Brief Summary

Postoperative multimodal analgesia methods occupy an essential place in modern anesthesia. The postoperative results of opioid analgesia are now at the bottom of the current problems due to its side effects. Longer-acting local anesthetics are now effective agents of analgesia. Investigators aimed to compare the two routine methods. Ultrasonic nerve blocks are the most important of multimodal analgesia in modern anesthesia. Suprascapular and axillary nerve blocks are routinely used as a safe method. It is a routine method used by periarticular local anesthetic surgeons. İnvestigators decided to compare which method effectively follows these two methods with the postoperative 24 pain scale method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2021

Completed
28 days until next milestone

Study Start

First participant enrolled

May 20, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

November 2, 2021

Status Verified

November 1, 2021

Enrollment Period

4 months

First QC Date

April 17, 2021

Last Update Submit

November 1, 2021

Conditions

Keywords

shoulder arthroplastysuprascapular blockaxillary nerve blockperiarticular injectionultrasound

Outcome Measures

Primary Outcomes (2)

  • Change from the baseline 11 point NRS (numeric rating Scala) Scala

    Possible scores range from 0 (no pain) to 10 ( worst possible pain). Change for 24 Hours.

    0 to 24 hours

  • Total opioid consumption, from the moment of exit from the operation to the 24th hour

    Each patient will be fitted with a patient controlled analgesia (PCA) device. The total tramadol requirement for both groups will be calculated.

    0 to 24 hours

Secondary Outcomes (1)

  • nausea and vomiting

    0 to 24 hours

Study Arms (2)

periarticular injection group (PI)

ACTIVE COMPARATOR

the group to be given a periarticular injection by an orthopedist

Procedure: shoulder periarticular injection, suprascapular and axillary nerve block

Combined suprascapular-axillary nerve block group (CSAB)

ACTIVE COMPARATOR

the group in which an anesthesiologist will perform combined suprascapular axillar border block under ultrasound guidance

Procedure: shoulder periarticular injection, suprascapular and axillary nerve block

Interventions

In the PI group, a mixture of 30 ml bupivacaine 0.5% and 30 ml saline solution will be injected by the orthopedist after the wound is closed. In the CSAB group, a total of 20 ml 0.5% bupivacaine, 10 ml to the suprascapular notch, 10 ml to the axillary nerve, will be administered preoperatively by the anesthesiologist under ultrasound guidance.

Combined suprascapular-axillary nerve block group (CSAB)periarticular injection group (PI)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being in the age range of 18-65
  • agree to participate in the study

You may not qualify if:

  • diabetic patients
  • chronic opioid use
  • patients with sensitivity to local anesthetics
  • patients with neuropathy
  • Patients who cannot use the PCA
  • cases returning to open surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Namık Kemal University

Tekirdağ, Süleymanpaşa, 59100, Turkey (Türkiye)

Location

Study Officials

  • M.Cavidan ARAR

    Prof.

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: prospective randomized trial, To compare the suprasacuplar-axillary nerve block combined with the periarticular injection method in shoulder arthroscopy cases.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 17, 2021

First Posted

April 22, 2021

Study Start

May 20, 2021

Primary Completion

September 15, 2021

Study Completion

October 1, 2021

Last Updated

November 2, 2021

Record last verified: 2021-11

Locations